Altimmune to report fourth quarter and full year 2021 financial results on march 15, 2022

Gaithersburg, md., march 08, 2022 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its fourth quarter and full year 2021 financial results on tuesday, march 15, 2022.

ALT Ratings Summary

ALT Quant Ranking